The expression of the Kif18A protein was higher in highly differentiated tumors, in patients with lymph node metastasis (vs no lymph node metastasis), adenocarcinoma, and in stage III NSCLC. This evidence concerns the gene KIF18A and metastatic malignant neoplasm in the lymph nodes.